Eyestem Research Profile
Key Indicators
- Authorised Capital ₹ 9.80 M
- Paid Up Capital ₹ 2.38 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 47.53%
- Profit Growth -82.40%
- Ebitda -101.99%
- Net Worth 0.87%
- Total Assets 3.87%
About Eyestem Research
Eyestem Research Private Limited (ERPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 25 August 2015 (Nine years and six months 15 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.80 M and a paid-up capital of Rs 2.38 M, as per Ministry of Corporate Affairs (MCA) records.
Jogin Desai, Suresh Ramu, Ramesh Byrapaneni, and Six other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999KA2015PTC164505
- Company No.
084306
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2015
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Research & Development
Who are the key members and board of directors at Eyestem Research?
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ramu  | Director | 07-Nov-2017 | Current |
| Subramanian Ramaswamy | Director | 13-Jan-2020 | Current |
| Jogin Desai | Director | 25-Aug-2015 | Current |
Gerardus Hoogland  | Director | 07-Sep-2020 | Current |
Dhruv Sareen  | Director | 01-Aug-2016 | Current |
Ashok Vohra  | Director | 07-Nov-2017 | Current |
Financial Performance of Eyestem Research.
Eyestem Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.53% increase. The company also saw a substantial fall in profitability, with a 82.4% decrease in profit. The company's net worth moved up by a moderate rise of 0.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eyestem Research?
In 2022, Eyestem Research had a promoter holding of 6.46% and a public holding of 93.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sigtuple Technologies Private LimitedRamesh Byrapaneni is a mutual person
Endiya Iksana Advisory Services LlpRamesh Byrapaneni is a mutual person
- Endiya Alamban Advisory Services Llp
Ramesh Byrapaneni is a mutual person
- Endiya Trustee Private Limited
Ramesh Byrapaneni is a mutual person
- Endiya Fund Advisors Private Limited
Ramesh Byrapaneni is a mutual person
Nkure Therapeutics Private LimitedAshok Vohra and Mahendra Rao are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eyestem Research?
Eyestem Research has a workforce of 1 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eyestem Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyestem Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Eyestem Research
Recent activity within the organization
- Annual General Meeting
Eyestem Research Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
- Director Appointment
Ramesh Babu Byrapaneni was appointed as a Nominee Director was appointed as a Nominee Director on 14 Jun 2024 & has been associated with this company since 8 months 24 days .
- Balance Sheet
Eyestem Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Director Appointment
Mahendra Surendra Rao was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 2 years 8 months .
- Director Appointment
Gerardus Adrianus Hoogland was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 4 years 6 months .
- Director Appointment
Subramanian Ramaswamy was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 5 years 1 month .
Recent News, Updates & Announcement
Biotech Firm Eyestem Partners with RetinAI to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology.Eyestem Research, a Bangalore-based biotechnology company specialising in cell therapy approaches, has entered a strategic partnership with ....
- Eyestem files for IND approval for its product to treat geographic atrophy.
Eyestem Research has announced the submission of IND application to CDSCO to start first in-human trials of Eyecyte-RPE™for subjects..
- Eyestem files for CDSCO approval for Eyecyte-RPE.
Eyecyte-RPE will be used to treat geographic atrophy Eyestem Research announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards Control Organization, Ind.
- Eyestem Files for IND Approval for Its Product to Treat Geographic Atrophy, the Largest Cause of Incurable Blindness in the World for People Over 50.
Dry age-related macular degeneration (dry AMD) is the largest cause of incurable blindness in the world for patients over 50 years. 170 mill....
- Bengaluru-based Eyestem announces US operations, appoints Ravi Achar as Head- North America Strategy.
Engages Stradling Yocca Carlson & Rauth as its US law firm Eyestem, a Bengaluru-based Cell Therapy company, with a focus on ophthalmology, has appointed Ravi Achar as Head- North America Strategy.
Frequently asked questions
What is the Incorporation or founding date of Eyestem Research Private Limited?
Eyestem Research Private Limited was incorporated on 25 Aug 2015.
What is authorized share capital and paid-up capital of Eyestem Research Private Limited?
The authorized share capital of Eyestem Research Private Limited is ₹ 9.80 M and paid-up capital is ₹ 2.38 M.
Who are the current board members & directors of Eyestem Research Private Limited?
Currently 9 directors are associated with Eyestem Research Private Limited.
- Jogin Bhairav Desai
- Suresh Ramu
- Ramesh Babu Byrapaneni
- Ashok Nana Vohra
- Subramanian Ramaswamy
- Gerardus Adrianus Hoogland
- Rajani Ravindra Battu
- Dhruv Sareen
- Mahendra Surendra Rao
What is the registered address of Eyestem Research Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Eyestem Research Private Limited is Centre For Cellular And Molecular Platforms Gkvk Campus Bellary Road, India, Bangalore, Karnataka, 560065.
What is the corporate identification number (CIN) and company number of Eyestem Research Private Limited?
The corporate identification number (CIN) of Eyestem Research Private Limited is U74999KA2015PTC164505 and the company number is 084306 as per Ministry of Corporate Affairs (MCA).
What is the official website of Eyestem Research Private Limited?
The Official website of Eyestem Research Private Limited is https://www.eyestem.com
What has been the recent revenue trend for Eyestem Research Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Eyestem Research Private Limited has risen by 47.53%.
How many employees does Eyestem Research Private Limited currently have?
As Per 2022 financial reports, 1 employees are currently employed by Eyestem Research Private Limited.
What change has been observed in the net worth of Eyestem Research Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Eyestem Research Private Limited has experienced an upsurge of 0.87%.
When was the last Balance Sheet of Eyestem Research Private Limited filed with the ROC?
The most recent Balance Sheet for Eyestem Research Private Limited was filed with the ROC on 31 Mar 2024.